Supply of Indium-111 (In-111) Labeled White Blood Cells (WBC)

The contract requires the supply of Indium-111 labeled autologous white blood cells for use in infection and inflammation imaging procedures, with preparation expected to occur either on-site or through a specialized radiopharmacy capable of handling radiopharmaceuticals. The product must meet strict quality and regulatory standards to ensure safety and efficacy in clinical imaging applications, and the vendor must demonstrate capability in processing patient-derived white blood cells with In-111 under controlled conditions to produce a consistent, sterile, and pyrogen-free radiopharmaceutical. This subcontract is issued under the Department of Veterans Affairs through the 250-NETWORK Contract Office 10 (36C250) and falls under NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The solicitation was posted on July 20, 2026, with a response deadline of August 13, 2026. There is no set-aside designation, and the place of performance is unspecified, suggesting the service may be delivered at multiple authorized locations. Vendors must be equipped to fulfill this specialized requirement efficiently, ensuring timely delivery and compliance with nuclear medicine and radiation safety protocols.